WASHINGTON, Feb. 15 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) announced today a new internet link with a renown lung cancer research center at the 5th Affiliated Hospital of Sun Yat-Sen University, in Zhuhai, China.

The link on LCA's homepage (Lung Cancer Alliance) will connect to the Zhuhai Relay Station and its Early Lung Cancer Research Program at the hospital and will provide a Simple Chinese Version (SCV) translation of the LCA website.

Xueguo Liu, MD,...

admin

ERYtech Pharma Signs an Agreement With M. D. Anderson Cancer Center to Develop a Companion Test for GRASPA® in Solid Tumors

February 15, 2010 08:24 AM Eastern Time

LYON, France & PHILADELPHIA, pa.--(BUSINESS WIRE)--ERYtech Pharma, a specialty pharma company located in France and in USA (Philadelphia), is pleased to announce a collaborative research agreement in the field of personalized medicine focusing on ERYtech’s flagship product, GRASPA®, which consists of red...

admin

By Paul Courson, CNN
February 8, 2010 7:55 p.m. EST

Washington (CNN) -- "Electronic cigarettes" that vaporize nicotine juice to inhale instead of smoke from burning tobacco do not deliver as promised, according to research at Virginia Commonwealth University.

"They are as effective at nicotine delivery as puffing on an unlit cigarette," said Dr. Thomas Eissenberg, at the school's Institute for Drug and Alcohol Studies.

His study, funded...

admin

Thu Feb 4, 2010 5:40am EST
Reuters
Source: Wired

Federal court hearings continued Tuesday on a lawsuit that could transform biotechnology in the United States by eliminating gene patents.

The case hinges around the claims of Utah-based Myriad Genetics on BRCA1 and BRCA2, a pair of genes closely linked to breast and ovarian cancer. Myriad “owns” the genes, and says its patents make it possible to profit on diagnostic tests. The company argues that if you remove...

admin

Tue Jan 26, 2010 5:36pm EST

* Merck to appeal decision on leading brain-cancer drug

* Teva generic awaiting U.S. approval

* Merck and Teva shares fractionally lower (Brings Merck response and detail of ruling higher; updates share movement)

By Ransdell Pierson

NEW YORK, Jan 26 (Reuters) - A federal court ruled on Tuesday that Merck & Co's (MRK.N) patent on Temodar, the world's top-selling brain cancer drug, is unenforceable, possibly...

admin